VEGF is highly expressed in HNSCCs and it is associated with lymph node metastasis and poor life expectancy, which suggest its potential as prognostic marker for this type of cancer (Chau and Haddad, 2016; Mineta et al., 2000). This evidence concerns the gene VEGFA and metastatic malignant neoplasm in the lymph nodes.